US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Medicus Pharma Ltd.

0.1599

-0.0011-0.68%

Volume:358.89K

Turnover:57.12K

Market Cap:10.10M

PE:-0.10

High:0.1619

Open:0.1582

Low:0.1551

Close:0.1610

52wk High:2.78

52wk Low:0.1440

Shares:63.18M

Float Shares:46.69M

Volume Ratio:1.01

T/O Rate:0.77%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.6597

EPS(LYR):-2.7356

ROE:-7446.11%

ROA:-110.67%

PB:-5.73

PE(LYR):-0.06

Loading ...

Overview Company News Filings

Medicus Pharma submits Protocol SKNJCT-005 to the FDA

Medicus Pharma submits FDA protocol for SkinJect registrational Gorlin syndrome study

Medicus Pharma Advances Skinject® Into Registrational Development for Gorlin Syndrome

THOMSON REUTERS

Medicus Pharma secures up to $22 million structured financing facility with institutional investor

Medicus Pharma Announces $22 Million Non-Dilutive Financing

THOMSON REUTERS

Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure

Medicus Pharma enters USD 22.86 million secured note deal with Streeterville Capital

Medicus Pharma reports Q1 EPS (31c), consensus (22c)

Medicus Pharma Ltd reports results for the quarter ended December 31 - Earnings Summary

Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate

Benzinga Earnings

Medicus Pharma Ltd - Q1 2026 Net Loss per Share $0.31

THOMSON REUTERS

Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million

Medicus Pharma Ltd expected to post a loss of 19 cents a share - Earnings Preview

Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)

Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma

Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc

THOMSON REUTERS

Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events

THOMSON REUTERS

Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/MDCX/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MDCX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","market":"US","secType":"STK","nameCN":"Medicus Pharma Ltd.","latestPrice":0.1599,"timestamp":1790865603013,"preClose":0.161,"halted":0,"volume":358886,"delay":0,"changeRate":-0.006832298136646072,"floatShares":46686672,"shares":63180600,"eps":-1.659689,"marketStatus":"Trading","change":-0.0011,"latestTime":"10-01 10:41:35 EDT","open":0.1582,"high":0.1619,"low":0.1551,"amount":57120.54339134,"amplitude":0.042236,"askPrice":0.1618,"askSize":500,"bidPrice":0.1556,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.659689,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":2,"adr":0,"listingDate":1731560400000,"exchange":"NASDAQ","adjPreClose":0.161,"preHourTrading":{"tag":"盘前","latestPrice":0.1619,"preClose":0.161,"latestTime":"09:25 EDT","volume":11348,"amount":1807.9085491600001,"timestamp":1790861120382,"change":0.0009,"changeRate":0.00559,"amplitude":0.060248},"postHourTrading":{"tag":"盘后","latestPrice":0.16,"preClose":0.161,"latestTime":"19:56 EDT","volume":70159,"amount":11318.3041,"timestamp":1790812574511,"change":-0.001,"changeRate":-0.006211,"amplitude":0.043478},"volumeRatio":1.013377},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MDCX\",,,,,undefined,":{"symbol":"MDCX","floatShares":46686672,"roa":"-110.67%","roe":"-7446.11%","lyrEps":-2.735593,"volumeRatio":1.013377,"shares":63180600,"dividePrice":0,"high":0.1619,"amplitude":0.042236,"preClose":0.161,"low":0.1551,"week52Low":0.144,"pbRate":"-5.73","week52High":2.78,"institutionHeld":0,"latestPrice":0.1599,"eps":-1.659689,"divideRate":0,"volume":358886,"delay":0,"ttmEps":-1.659689,"open":0.1582,"prevYearClose":1.53,"prevWeekClose":0.1524,"prevMonthClose":0.161,"prevQuarterClose":0.161,"fiveDayClose":0.1588,"twentyDayClose":0.2599,"sixtyDayClose":0.4285},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MDCX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"MDCX","fiscalQuarterEnding":"2026/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-0.21},{"market":"US","date":"2026-05-14","symbol":"MDCX","fiscalQuarterEnding":"2026/03","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.31},{"market":"US","date":"2026-03-25","symbol":"MDCX","fiscalQuarterEnding":"2025/12","expectedEps":-0.32,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774411200000,"reportTimeType":"post","actualEps":-0.82},{"date":"2025-11-14","symbol":"MDCX","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763154000000,"name":null,"time":"Post-Mkt","dateTimestamp":1763096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MDCX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MDCX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1785297600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MDCX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MDCX","date":"2026-09-29","current":-0.097006,"percent":0.99635,"low":-3.23298,"twenty":-2.115799,"median":-0.506062,"eighty":-0.311804,"high":-0.169596,"avg":-1.037434,"sd":0.945416,"marketCap":9609770},"quantilePoints":[{"date":"2025-08-29","current":-2.084531,"twenty":-2.272139,"median":-2.126221,"eighty":-2.109545,"marketCap":35632532},{"date":"2025-09-05","current":-1.907346,"twenty":-2.205434,"median":-2.115799,"eighty":-2.053263,"marketCap":32603766},{"date":"2025-09-12","current":-2.345097,"twenty":-2.211687,"median":-2.12101,"eighty":-2.053263,"marketCap":40086598},{"date":"2025-09-19","current":-2.532705,"twenty":-2.511859,"median":-2.178335,"eighty":-2.080362,"marketCap":43293526},{"date":"2025-09-26","current":-2.817408,"twenty":-2.759151,"median":-2.287772,"eighty":-2.103292,"marketCap":48160186},{"date":"2025-10-03","current":-3.005474,"twenty":-2.869667,"median":-2.511859,"eighty":-2.115799,"marketCap":51374941},{"date":"2025-10-10","current":-3.005474,"twenty":-2.994879,"median":-2.558762,"eighty":-2.122052,"marketCap":51374941},{"date":"2025-10-17","current":-2.885734,"twenty":-2.976858,"median":-2.720313,"eighty":-2.151236,"marketCap":49328130},{"date":"2025-10-24","current":-2.909682,"twenty":-2.974342,"median":-2.774974,"eighty":-2.174166,"marketCap":49737492},{"date":"2025-10-31","current":-2.957578,"twenty":-2.974342,"median":-2.817408,"eighty":-2.178335,"marketCap":50556216},{"date":"2025-11-07","current":-2.897708,"twenty":-2.962368,"median":-2.809662,"eighty":-2.228364,"marketCap":49532811},{"date":"2025-11-14","current":-2.706124,"twenty":-2.950394,"median":-2.817408,"eighty":-2.292984,"marketCap":46257915},{"date":"2025-11-21","current":-1.28141,"twenty":-2.950394,"median":-2.789942,"eighty":-2.178335,"marketCap":44939453},{"date":"2025-11-28","current":-1.355609,"twenty":-2.936025,"median":-2.763,"eighty":-2.119968,"marketCap":48464116},{"date":"2025-12-05","current":-1.183077,"twenty":-2.916866,"median":-2.742046,"eighty":-2.04284,"marketCap":42295956},{"date":"2025-12-12","current":-1.201563,"twenty":-2.904892,"median":-2.700137,"eighty":-1.376181,"marketCap":42956830},{"date":"2025-12-19","current":-1.022869,"twenty":-2.897708,"median":-2.63428,"eighty":-1.31987,"marketCap":36568379},{"date":"2025-12-26","current":-0.955088,"twenty":-2.897553,"median":-2.584818,"eighty":-1.266827,"marketCap":34145173},{"date":"2026-01-02","current":-1.074791,"twenty":-2.896932,"median":-2.511859,"eighty":-1.220048,"marketCap":38424640},{"date":"2026-01-09","current":-1.095865,"twenty":-2.885734,"median":-2.329463,"eighty":-1.179996,"marketCap":39178064},{"date":"2026-01-16","current":-0.976444,"twenty":-2.885734,"median":-2.178335,"eighty":-1.123965,"marketCap":34908660},{"date":"2026-01-23","current":-0.94132,"twenty":-2.866576,"median":-2.167912,"eighty":-1.101485,"marketCap":33652952},{"date":"2026-01-30","current":-0.878097,"twenty":-2.861786,"median":-2.115799,"eighty":-1.061072,"marketCap":31392680},{"date":"2026-02-06","current":-0.765701,"twenty":-2.861786,"median":-2.074108,"eighty":-1.022014,"marketCap":27374416},{"date":"2026-02-13","current":-0.709738,"twenty":-2.853549,"median":-1.933403,"eighty":-0.974021,"marketCap":25373688},{"date":"2026-02-20","current":-0.786136,"twenty":-2.850483,"median":-1.381324,"eighty":-0.961937,"marketCap":28104981},{"date":"2026-02-27","current":-0.97195,"twenty":-2.849812,"median":-1.344224,"eighty":-0.949581,"marketCap":34747976},{"date":"2026-03-06","current":-0.484474,"twenty":-2.849812,"median":-1.300152,"eighty":-0.949581,"marketCap":17320333},{"date":"2026-03-13","current":-0.412761,"twenty":-2.835443,"median":-1.263181,"eighty":-0.891018,"marketCap":14756541},{"date":"2026-03-20","current":-0.412761,"twenty":-2.825864,"median":-1.220048,"eighty":-0.847322,"marketCap":14756541},{"date":"2026-03-27","current":-0.387698,"twenty":-2.82079,"median":-1.201563,"eighty":-0.836077,"marketCap":18330934},{"date":"2026-04-02","current":-0.349652,"twenty":-2.811211,"median":-1.179996,"eighty":-0.820403,"marketCap":16532085},{"date":"2026-04-10","current":-0.367967,"twenty":-2.792337,"median":-1.125793,"eighty":-0.786136,"marketCap":17398052},{"date":"2026-04-17","current":-0.250001,"twenty":-2.775573,"median":-1.109135,"eighty":-0.744685,"marketCap":11820441},{"date":"2026-04-24","current":-0.276475,"twenty":-2.764797,"median":-1.099378,"eighty":-0.508201,"marketCap":13072156},{"date":"2026-05-01","current":-0.235266,"twenty":-2.75402,"median":-1.088841,"eighty":-0.417566,"marketCap":11123732},{"date":"2026-05-08","current":-0.277717,"twenty":-2.74923,"median":-1.069002,"eighty":-0.412761,"marketCap":13130880},{"date":"2026-05-15","current":-0.393186,"twenty":-2.733353,"median":-1.041354,"eighty":-0.401798,"marketCap":18590424},{"date":"2026-05-22","current":-0.308017,"twenty":-2.714637,"median":-1.024243,"eighty":-0.38811,"marketCap":15777036},{"date":"2026-05-29","current":-0.354651,"twenty":-2.703729,"median":-1.018593,"eighty":-0.376126,"marketCap":18165658},{"date":"2026-06-05","current":-0.402361,"twenty":-2.691755,"median":-0.976444,"eighty":-0.374724,"marketCap":20609444},{"date":"2026-06-12","current":-0.35842,"twenty":-2.672597,"median":-0.968141,"eighty":-0.372398,"marketCap":18358733},{"date":"2026-06-18","current":-0.378775,"twenty":-2.63428,"median":-0.962395,"eighty":-0.367967,"marketCap":19401342},{"date":"2026-06-26","current":-0.492235,"twenty":-2.63428,"median":-0.955088,"eighty":-0.371628,"marketCap":25212882},{"date":"2026-07-02","current":-0.442458,"twenty":-2.59471,"median":-0.94132,"eighty":-0.37203,"marketCap":22663265},{"date":"2026-07-10","current":-0.467347,"twenty":-2.543128,"median":-0.915037,"eighty":-0.3732,"marketCap":23938074},{"date":"2026-07-17","current":-0.449095,"twenty":-2.516028,"median":-0.871896,"eighty":-0.374395,"marketCap":23003214},{"date":"2026-07-24","current":-0.424981,"twenty":-2.511859,"median":-0.846653,"eighty":-0.374627,"marketCap":21768066},{"date":"2026-07-31","current":-0.290474,"twenty":-2.411802,"median":-0.843141,"eighty":-0.371929,"marketCap":14878433},{"date":"2026-08-07","current":-0.34025,"twenty":-2.326336,"median":-0.835949,"eighty":-0.363051,"marketCap":17428051},{"date":"2026-08-14","current":-0.353971,"twenty":-2.282561,"median":-0.821824,"eighty":-0.360424,"marketCap":20056990},{"date":"2026-08-21","current":-0.30351,"twenty":-2.211687,"median":-0.793282,"eighty":-0.354379,"marketCap":17197762},{"date":"2026-08-28","current":-0.298604,"twenty":-2.178335,"median":-0.778989,"eighty":-0.346389,"marketCap":16919767},{"date":"2026-09-04","current":-0.190112,"twenty":-2.172081,"median":-0.757549,"eighty":-0.339549,"marketCap":10772294},{"date":"2026-09-11","current":-0.179965,"twenty":-2.151236,"median":-0.709738,"eighty":-0.335,"marketCap":10197350},{"date":"2026-09-18","current":-0.190224,"twenty":-2.122052,"median":-0.541685,"eighty":-0.329543,"marketCap":10778612},{"date":"2026-09-25","current":-0.177066,"twenty":-2.115799,"median":-0.506615,"eighty":-0.313898,"marketCap":10033080},{"date":"2026-09-29","current":-0.169596,"twenty":-2.115799,"median":-0.506062,"eighty":-0.311804,"marketCap":9609770}],"updateTime":1790825321028},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MDCX\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640079989","title":"Medicus Pharma submits Protocol SKNJCT-005 to the FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2640079989","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640079989?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:37","pubTimestamp":1780493843,"startTime":"0","endTime":"0","summary":"Medicus Pharma (MDCX) announced the submission of Protocol SKNJCT-005 to the FDA under the company’s existing investigational new drug, or IND, app...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-submits-protocol-sknjct-005-to-the-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-submits-protocol-sknjct-005-to-the-fda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4139","MDCX","LABU","IND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901615","title":"Medicus Pharma submits FDA protocol for SkinJect registrational Gorlin syndrome study","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901615","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901615?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:01","pubTimestamp":1780488108,"startTime":"0","endTime":"0","summary":"Medicus submitted a Phase 2b registrational protocol for SkinJect in Gorlin syndrome under its existing FDA IND.Trial targets up to 50 patients; primary endpoint is complete visual clearance in at least 50% of selected lesions at Week 10.FDA orphan drug designation application filed in April; incentives could include waiver of NDA fees above USD 5 million, seven years of exclusivity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief on June 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL713kk1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901569","title":"Medicus Pharma Advances Skinject® Into Registrational Development for Gorlin Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901569","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901569?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:00","pubTimestamp":1780488001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUABNVXFF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638981146","title":"Medicus Pharma secures up to $22 million structured financing facility with institutional investor","url":"https://stock-news.laohu8.com/highlight/detail?id=2638981146","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638981146?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:03","pubTimestamp":1779969816,"startTime":"0","endTime":"0","summary":"Medicus Pharma entered a definitive structured financing facility of up to USD 22 million with an institutional investor.USD 12 million will be funded immediately; USD 10 million will be held in a collateralized deposit account for milestone-based releases.Facility includes a USD 12.86 million secured promissory note at 8.75% interest with a 6.5% original issue discount.Second tranche is a USD 10 million secured promissory note at 5% interest with no original issue discount.Pro forma cash is expected to rise to about USD 30 million; projected operating runway exceeds 24 months; notes mature in 18 months.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL39VCP7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BN0W2W23.USD","NDAQ","SG9999014005.SGD","LU2210150020.SGD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","BK4588","BK4112","SG9999014013.SGD","LU2210149790.SGD","BK4139","IE00BGHQF748.EUR","SG9999014021.USD","MDCX","LU0314104364.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638698623","title":"Medicus Pharma Announces $22 Million Non-Dilutive Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=2638698623","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638698623?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:00","pubTimestamp":1779969607,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUAC3YKWN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638634807","title":"Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure","url":"https://stock-news.laohu8.com/highlight/detail?id=2638634807","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638634807?lang=en_us&edition=fundamental","pubTime":"2026-05-28 06:19","pubTimestamp":1779920379,"startTime":"0","endTime":"0","summary":"An announcement from Medicus Pharma Ltd ( ($MDCX) ) is now available. On May 27, 2026, Medicus Pharma Ltd. closed a $22.86 million secured financin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-financing-amid-nasdaq-compliance-pressure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medicus-pharma-secures-financing-amid-nasdaq-compliance-pressure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX","BK4139","NQmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638856639","title":"Medicus Pharma enters USD 22.86 million secured note deal with Streeterville Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2638856639","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638856639?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:45","pubTimestamp":1779914735,"startTime":"0","endTime":"0","summary":"Medicus Pharma closed a note purchase agreement with Streeterville Capital for two secured promissory notes totaling USD 22.86 million.Streeterville funded USD 12 million at closing; another USD 10 million was placed in a controlled deposit account at Lakeside Bank.Secured Promissory Note A-1 carries 8.75% interest, an USD 834,225 original issue discount; matures 18 months from issuance.Secured Promissory Note B carries 5% interest; no original issue discount; matures 18 months from issuance.About USD 2.5 million repaid and extinguished a YA II PN debenture; proceeds earmarked for clinical development, business development, general corporate uses.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL1shSs3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635643724","title":"Medicus Pharma reports Q1 EPS (31c), consensus (22c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635643724","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635643724?lang=en_us&edition=fundamental","pubTime":"2026-05-15 06:18","pubTimestamp":1778797121,"startTime":"0","endTime":"0","summary":"“During the first quarter of 2026, Medicus continued to execute on its transformation into a diversified clinical-stage biotechnology company, high...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medicus-pharma-reports-q1-eps-31c-consensus-22c-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medicus-pharma-reports-q1-eps-31c-consensus-22c-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729315","title":"Medicus Pharma Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729315?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:00","pubTimestamp":1778792454,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd reports results for the quarter ended December 31 - Earnings SummaryMedicus Pharma Ltd MDCX.OQ reported a quarterly adjusted loss of 31 cents per share for the quarter ended Decembe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nL8N41R2JD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726585","title":"Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726585","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726585?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:34","pubTimestamp":1778790882,"startTime":"0","endTime":"0","summary":"Medicus Pharma (NASDAQ:MDCX) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.19) by 63.16 percent. This is a 26.19 percent increase over losses of $(0.42) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52582192/medicus-pharma-q1-eps-0-31-misses-0-19-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Medicus Pharma Q1 EPS $(0.31) Misses $(0.19) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635726743","title":"Medicus Pharma Ltd - Q1 2026 Net Loss per Share $0.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2635726743","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635726743?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nTUA8M1DKT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635772644","title":"Medicus Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635772644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635772644?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:30","pubTimestamp":1778790600,"startTime":"0","endTime":"0","summary":"Company Advances SkinJect and Teverelix Clinical Programs While Strengthening Financing Flexibility and Expanding Strategic Development InitiativesPHILADELPHIA, May  14, 2026  (GLOBE NEWSWIRE) -- Medi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/14/3295423/0/en/Medicus-Pharma-Reports-First-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4585","BK4139","LABU","LU1169589451.USD","MDCX","BK4023","PD","BK4588","MNA","BCC","LU1169590202.USD","BK4567"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635237397","title":"Medicus Pharma Q1 FY26 net loss widens 77.22% to $9.04 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635237397","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635237397?lang=en_us&edition=fundamental","pubTime":"2026-05-15 04:12","pubTimestamp":1778789556,"startTime":"0","endTime":"0","summary":"Medicus Pharma posted a net loss of USD 9.04 million for the quarter ended March 31, 2026, widening from the prior-year period; loss per share narrowed to USD 0.31.Operating loss widened to USD 8.6 million as total operating expenses climbed 67.7% to USD 8.6 million.General and administrative expense rose 88.9% to USD 5.89 million, while R&D increased 34.8% to USD 2.7 million.Phase 2 SKNJCT-003 SkinJect dataset showed 73% clinical clearance in the 200-g cohort at Day 57, with FDA “study may proceed” clearance received to start a Phase 2b dose-optimization study of Teverelix in advanced prostate cancer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medicus Pharma Ltd. published the original content used to generate this news brief via ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL1mMtjl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634467553","title":"Medicus Pharma Ltd  expected to post a loss of 19 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634467553","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634467553?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:02","pubTimestamp":1778274128,"startTime":"0","endTime":"0","summary":"Medicus Pharma Ltd  expected to post a loss of19cents a share - Earnings Preview Medicus Pharma Ltd MDCX.OQ MDCX.O is expected to  show no change in quarterly revenue when it reports  results on May 1","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nL8N41L2N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633017877","title":"Analysts Are Bullish on Top Healthcare Stocks: Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633017877","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633017877?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:50","pubTimestamp":1778179812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Zevra Therapeutics (ZVRA), Medicus Pharma Ltd (MDCX)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-zevra-therapeutics-zvra-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-zevra-therapeutics-zvra-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BLSX","BK4137","BK4112","MDCX","BK4588","BK4585","LABU","LU0029874061.USD","BK4139","BK4007","XBI","ZVRA","BLSG","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187782","title":"Medicus reports positive dose-response in Phase 2 SkinJect trial for basal cell carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187782?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:32","pubTimestamp":1778067154,"startTime":"0","endTime":"0","summary":"Medicus Pharma reported results from a pre-specified expanded Phase 2 analysis of SKNJCT-003 testing its doxorubicin microneedle array for nodular basal cell carcinoma, adding to previously disclosed topline data from broader randomized enrollment.Updated review showed a clearer dose-response signal, with higher-dose treatment delivering the strongest overall clearance pattern versus device-only control.Separation versus control strengthened over follow-up, supporting a drug-driven effect rather than a short-lived device response.Safety profile remained favorable, with no drug-related serious adverse events reported and no signs of systemic doxorubicin toxicity.Dataset is being positioned to support end-of-Phase 2 talks with FDA on a registration path, including selection of dose and target patient population.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL10vV0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","SG9999014039.USD","SG9999014021.USD","BK4585","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","BK4112","BK4139","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","IE00BKPKM429.USD","MDCX","LU2210149790.SGD","SG9999014013.SGD","BK4588","LU0314104364.USD","SG9999014005.SGD","IE00BN0W2V16.EUR","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187796","title":"Medicus Pharma Ltd - Announces Positive Dose Response in Phase 2 Sknjct-003 Study for Bcc","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187796","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187796?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067050,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J05G:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187791","title":"Medicus Pharma Ltd - D-Mna Shows Favorable Safety Profile With No Drug-Related Serious Adverse Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187791","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187791?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067050,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nFWN41J05G:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MDCX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180180","title":"Medicus Pharma Announces Results from Pre-Specified Expanded Phase 2 SKNJCT-003 Data Analysis Demonstrating Positive Dose-Response","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180180","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633180180?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:30","pubTimestamp":1778067000,"startTime":"0","endTime":"0","summary":"200g Cohort Achieves 55% Complete Response at Day 57 Emerging as Registrational Grade Lead RegimenPHILADELPHIA, May  06, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (\"Medicus\" or the \"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/06/3288692/0/en/Medicus-Pharma-Announces-Results-from-Pre-Specified-Expanded-Phase-2-SKNJCT-003-Data-Analysis-Demonstrating-Positive-Dose-Response.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395692","title":"Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395692","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630395692?lang=en_us&edition=fundamental","pubTime":"2026-04-27 19:30","pubTimestamp":1777289400,"startTime":"0","endTime":"0","summary":"Builds Support for Accelerated Access to SkinJect for Gorlin Syndrome patients with a Rare Autosomal Dominant DiseasePHILADELPHIA, April  27, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/27/3281511/0/en/Medicus-Pharma-CEO-meets-with-lawmakers-on-Energy-Commerce-Committee-on-Capitol-Hill.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","MDCX","LU1169589451.USD","PD","BCC","IND","LU1169590202.USD","BK4139","BK4567","BK4023","MNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":93,"code":"91000000","status":"200"}]}}